INS and Hyperglycemia: Altogether, results shown in Figure 1 indicate that oral ABA, administered either before or after onset of hyperglycemia in a multiple low-dose STZ protocol of diabetes induction, improved the glycemia profile, the response to a glucose load, and the effect of low-dose insulin.